Nicotine - Effects of Messaging: Difference between revisions

Line 10:

*"By contrast, messages that address efficacy beliefs can increase hope, knowledge of cessation supports and motivation, thus supporting adaptive responses to smoking health risks."

*Full text in PDF.

*Note this study is listed in both the positive outcomes and unintended consequences sections.

**Citation: Lillian Brinken, Kate Shiells, Stuart G Ferguson, Stefania Franja, Anna Blackwell, Claire Braboszcz, Olivia M Maynard, Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS, Nicotine & Tobacco Research, 2024;, ntae297, https://doi.org/10.1093/ntr/ntae297

***Acknowledgement: This study was supported by an ESRC New Investigator‘s Award, awarded to Dr Olivia Maynard (ES/R003424/1) and Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/7). Stuart Ferguson has provided expert advice to various pharmaceutical companies and has received researcher-initiated project grant funding (through the GRAND initiative) and travel funds from Pfizer. These companies are not involved in the current study. All other project team members report no conflicts of interest.

===2017: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319257/ Internalized smoking stigma in relation to quit intentions, quit attempts, and current e-cigarette use]===

*Note this study is listed in both the positive outcomes and unintended consequences sections.

*Consistent with previous research we have found that smokers’ who reported greater feelings of stigmatization about their smoking were more likely to report having made recent quit attempts and report a stronger intention quit smoking in the future.

**Citation: O'Connor RJ, Rees VW, Rivard C, Hatsukami DK, Cummings KM. Internalized smoking stigma in relation to quit intentions, quit attempts, and current e-cigarette use. Subst Abus. 2017 Jul-Sep;38(3):330-336. doi: 10.1080/08897077.2017.1326999. Epub 2017 May 8. PMID: 28481713; PMCID: PMC6319257.

***Acknowledgement: This work was supported by a cooperative agreement from the National Cancer Institute (U19CA157345). The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. KMC has received grant funding from Pfizer, Inc to study the impact of a hospital-based tobacco cessation intervention and also has served as an expert witness in litigation filed against the tobacco industry. The remaining authors declare they have no conflicts of interest.

=Unintended Consequences=

Line 17:

Line 24:

===2024: [https://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/ntae297/7921069 Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS]===

*"Participants in the present study described how GHWLs [graphic health warning labels] were experienced as stigmatising in the context of broader policies leading to denormalisation of smoking. They felt smokingrelated stigma negatively impacted their motivation to quit and confidence to do so. In light of these and other similar findings35,37, we suggest policies intended to promote denormalisation be re-considered."

*Note this study is in both the positive outcomes and the unintended consequences sections.

*Full text in PDF.

**Citation: Lillian Brinken, Kate Shiells, Stuart G Ferguson, Stefania Franja, Anna Blackwell, Claire Braboszcz, Olivia M Maynard, Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS, Nicotine & Tobacco Research, 2024;, ntae297, https://doi.org/10.1093/ntr/ntae297

Line 36:

Line 44:

**Citation: Lozano P, Thrasher JF, Forthofer M, Hardin J, Shigematsu LMR, Arillo Santillán E, Fleischer NL. Smoking-Related Stigma: A Public Health Tool or a Damaging Force? Nicotine Tob Res. 2020 Jan 27;22(1):96-103. doi: 10.1093/ntr/nty151. PMID: 30053141; PMCID: PMC7297009.

***Acknowledgement: Funding for data collection came from the Mexican Consejo Nacional de Ciencia y Tecnología (Salud-2007-C01-70032), with additional funding for analysis provided by the National Cancer Institute at the National Institutes of Health (P01 CA138389), Canadian Institutes for Health Research (57897, 79551, and 115016), and GTF was supported by a Senior Investigator Award from Ontario Institute for Cancer Research and by a Prevention Scientist Award from the Canadian Cancer Research Institute.

===2017: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319257/ Internalized smoking stigma in relation to quit intentions, quit attempts, and current e-cigarette use]===

*Note this study is listed in both the positive outcomes and unintended consequences sections.

*It is also important to recognize the potential negative consequences associated with stigmatizing smokers, who may seek ways to evade stigma by segregating themselves into groups accepting of smoking and perhaps fostering the development of fatalistic attitudes about their ability to change their smoking behavior, which make quitting smoking harder to accomplish. Thus, behavioral interventions for smoking cessation might include addressing stigma-related issues as part of the quitting process.

**Citation: O'Connor RJ, Rees VW, Rivard C, Hatsukami DK, Cummings KM. Internalized smoking stigma in relation to quit intentions, quit attempts, and current e-cigarette use. Subst Abus. 2017 Jul-Sep;38(3):330-336. doi: 10.1080/08897077.2017.1326999. Epub 2017 May 8. PMID: 28481713; PMCID: PMC6319257.

***Acknowledgement: This work was supported by a cooperative agreement from the National Cancer Institute (U19CA157345). The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. KMC has received grant funding from Pfizer, Inc to study the impact of a hospital-based tobacco cessation intervention and also has served as an expert witness in litigation filed against the tobacco industry. The remaining authors declare they have no conflicts of interest.

@@ Line 10: / Line 10: @@
 *"By contrast, messages that address efficacy beliefs can increase hope, knowledge of cessation supports and motivation, thus supporting adaptive responses to smoking health risks."
 *Full text in PDF.
+*Note this study is listed in both the positive outcomes and unintended consequences sections.
 **Citation: Lillian Brinken, Kate Shiells, Stuart G Ferguson, Stefania Franja, Anna Blackwell, Claire Braboszcz, Olivia M Maynard, Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS, Nicotine & Tobacco Research, 2024;, ntae297, https://doi.org/10.1093/ntr/ntae297
 ***Acknowledgement: This study was supported by an ESRC New Investigator‘s Award, awarded to Dr Olivia Maynard (ES/R003424/1) and Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/7). Stuart Ferguson has provided expert advice to various pharmaceutical companies and has received researcher-initiated project grant funding (through the GRAND initiative) and travel funds from Pfizer. These companies are not involved in the current study. All other project team members report no conflicts of interest.
+===2017: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319257/ Internalized smoking stigma in relation to quit intentions, quit attempts, and current e-cigarette use]===
+*Note this study is listed in both the positive outcomes and unintended consequences sections.
+*Consistent with previous research we have found that smokers’ who reported greater feelings of stigmatization about their smoking were more likely to report having made recent quit attempts and report a stronger intention quit smoking in the future.
+**Citation: O'Connor RJ, Rees VW, Rivard C, Hatsukami DK, Cummings KM. Internalized smoking stigma in relation to quit intentions, quit attempts, and current e-cigarette use. Subst Abus. 2017 Jul-Sep;38(3):330-336. doi: 10.1080/08897077.2017.1326999. Epub 2017 May 8. PMID: 28481713; PMCID: PMC6319257.
+***Acknowledgement: This work was supported by a cooperative agreement from the National Cancer Institute (U19CA157345). The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. KMC has received grant funding from Pfizer, Inc to study the impact of a hospital-based tobacco cessation intervention and also has served as an expert witness in litigation filed against the tobacco industry. The remaining authors declare they have no conflicts of interest.
 =Unintended Consequences=
@@ Line 17: / Line 24: @@
 ===2024: [https://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/ntae297/7921069 Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS]===
 *"Participants in the present study described how GHWLs [graphic health warning labels] were experienced as stigmatising in the context of broader policies leading to denormalisation of smoking. They felt smokingrelated stigma negatively impacted their motivation to quit and confidence to do so. In light of these and other similar findings35,37, we suggest policies intended to promote denormalisation be re-considered."
+*Note this study is in both the positive outcomes and the unintended consequences sections.
 *Full text in PDF.
 **Citation: Lillian Brinken, Kate Shiells, Stuart G Ferguson, Stefania Franja, Anna Blackwell, Claire Braboszcz, Olivia M Maynard, Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS, Nicotine & Tobacco Research, 2024;, ntae297, https://doi.org/10.1093/ntr/ntae297
@@ Line 36: / Line 44: @@
 **Citation: Lozano P, Thrasher JF, Forthofer M, Hardin J, Shigematsu LMR, Arillo Santillán E, Fleischer NL. Smoking-Related Stigma: A Public Health Tool or a Damaging Force? Nicotine Tob Res. 2020 Jan 27;22(1):96-103. doi: 10.1093/ntr/nty151. PMID: 30053141; PMCID: PMC7297009.
 ***Acknowledgement: Funding for data collection came from the Mexican Consejo Nacional de Ciencia y Tecnología (Salud-2007-C01-70032), with additional funding for analysis provided by the National Cancer Institute at the National Institutes of Health (P01 CA138389), Canadian Institutes for Health Research (57897, 79551, and 115016), and GTF was supported by a Senior Investigator Award from Ontario Institute for Cancer Research and by a Prevention Scientist Award from the Canadian Cancer Research Institute.
+===2017: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319257/ Internalized smoking stigma in relation to quit intentions, quit attempts, and current e-cigarette use]===
+*Note this study is listed in both the positive outcomes and unintended consequences sections.
+*It is also important to recognize the potential negative consequences associated with stigmatizing smokers, who may seek ways to evade stigma by segregating themselves into groups accepting of smoking and perhaps fostering the development of fatalistic attitudes about their ability to change their smoking behavior, which make quitting smoking harder to accomplish. Thus, behavioral interventions for smoking cessation might include addressing stigma-related issues as part of the quitting process.
+**Citation: O'Connor RJ, Rees VW, Rivard C, Hatsukami DK, Cummings KM. Internalized smoking stigma in relation to quit intentions, quit attempts, and current e-cigarette use. Subst Abus. 2017 Jul-Sep;38(3):330-336. doi: 10.1080/08897077.2017.1326999. Epub 2017 May 8. PMID: 28481713; PMCID: PMC6319257.
+***Acknowledgement: This work was supported by a cooperative agreement from the National Cancer Institute (U19CA157345). The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. KMC has received grant funding from Pfizer, Inc to study the impact of a hospital-based tobacco cessation intervention and also has served as an expert witness in litigation filed against the tobacco industry. The remaining authors declare they have no conflicts of interest.